Lacosamide Medical Valley

Lacosamide, the active ingredient in Lacosamide Medical Valley, is an anticonvulsant presented as an oral tablet for oral use. It treats partial‑onset seizures and epilepsy in adults.

GNH USA supplies Lacosamide Medical Valley as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Lacosamide is an anticonvulsant used in the management of seizure disorders. It is indicated for: - Partial‑onset seizures: reduces the frequency of focal seizures when used as adjunct therapy. - Epilepsy: contributes to overall seizure control in patients with epilepsy. - Adjunct therapy for refractory focal seizures: provides additional seizure reduction when first‑line agents are insufficient.

Lacosamide may cause a range of adverse reactions, most of which are dose‑related and reversible.

Common Side Effects: - Dizziness: sensation of light‑headedness or unsteadiness. - Nausea: mild to moderate stomach upset. - Headache: intermittent or persistent pain. - Fatigue: feeling unusually tired. - Tremor: involuntary shaking of limbs. - Vision changes: blurred or double vision.

Serious or Rare Side Effects: - Cardiac arrhythmia: irregular heart rhythm, especially PR‑interval prolongation. - Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Suicidal thoughts: emergence of depressive symptoms or suicidal ideation. - Hepatic dysfunction: elevated liver enzymes indicating liver stress. - Hypersensitivity: anaphylaxis or severe allergic response. - Respiratory depression: difficulty breathing in rare cases.

When prescribing Lacosamide, clinicians should consider several safety aspects. - Cardiac monitoring: assess ECG for PR‑interval prolongation before and during therapy. - Renal function: adjust use in patients with severe renal impairment. - Hepatic function: monitor liver enzymes periodically. - Pregnancy: avoid use unless potential benefit justifies potential risk, as safety data are limited. - Concomitant CNS depressants: use caution as additive sedation may occur. - Store at ambient temperature: keep below 25 °C in the original container, protect from moisture and light.

Lacosamide can interact with other medicines, altering efficacy or safety.

Major Interactions (Avoid):\n- Strong CYP3A4 inducers (e.g., carbamazepine, phenytoin): may markedly reduce lacosamide plasma levels. - Class III anti‑arrhythmic agents (e.g., amiodarone): increase risk of cardiac conduction abnormalities.

Moderate Interactions (Monitor Closely): - Other antiepileptic drugs (e.g., valproate, lamotrigine): may require dose adjustments. - CNS depressants (e.g., benzodiazepines, opioids): may enhance sedation. - Alcohol: can increase dizziness and coordination problems. - Diuretics (e.g., furosemide): may affect renal clearance of lacosamide. - Antihypertensives: monitor blood pressure as additive effects are possible.